Background: Circular external fixation for limb-lengthening is associated with frequent and numerous complications.
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to decrease the number of complications 7 . However, complications related to pin fixation remain. Implantable devices capable of both fixation and lengthening, obviating the need for external fixation altogether [13] [14] [15] [16] [17] [18] , have thus generated strong interest 19, 20 .
Comparison of the outcomes in patients undergoing limb-lengthening is challenged by the lack of universally accepted, comprehensive, and objective complication classification systems. Reports have often involved patients with heterogeneous diagnoses 2, 4, 5, 21 . Congenital femoral deficiency has been reported to occur in one of every 52,000 live births [22] [23] [24] [25] [26] [27] [28] . Patients with congenital femoral deficiency have been reported to incur a higher rate of complications associated with femoral lengthening than those without the disorder 2, 6, 29 .
The purpose of the present study was to compare the outcomes and complications of femoral lengthening in pediatric patients with congenital femoral deficiency treated with either circular external fixation or a fully implantable, motorized, intramedullary lengthening nail, using an outcome-specific complication classification system.
Materials and Methods

T
he institutional review board at our institution approved this study. FITBONE is not currently approved by the U.S. Food and Drug Administration (FDA). This nail was used at our institution with individual, institutional administrative, institutional review board, and FDA approval on a compassionate-use basis. Patients so treated are restricted to standard-of-care treatment and investigations (other than use of the device itself) and cannot be enrolled in a research study. Their medical and radiographic records may, however, be evaluated in a retrospective manner with institutional review board approval. All patients who were petitioned for the use of this device had a substantial shortening, had refused shortening of the contralateral limb, had refused initial or repeat lengthening with circular fixation, were skeletally mature, and had a femur of appropriate size and shape to allow installation of the device. All patients and their families were made aware of the experimental status of this device with the FDA and consented to its use. Per institutional review board and FDA stipulations, the present investigation is a strictly retrospective chart and radiographic review, which is a considerable limitation to the study. Both circular external fixation devices used for the patients in this study were approved by the FDA. The FITBONE TAA femoral nail is a stainless steel, straight nail capable of 40 to 80 mm of distraction, depending on the specific model used. A radiofrequency wave transmitter activates the electric spindle motor housed in the nail by transmitting waves to a subcutaneous antenna-receiver, which converts the waves into small electrical impulses. Twenty-seven individual activations (divided into nine pulses sent three times daily) result in a millimeter of distraction. The rate of distraction can be modified by altering the number of activations. All FITBONE devices were inserted in a retrograde femoral fashion after careful preoperative analysis of the deformity, using the reverse planning method of Baumgart 30 (Figs. 1-A through 1-D). After complete osseous consolidation, the implants were removed, per the manufacturer's recommendation. The present retrospective chart review was undertaken to identify patient demographics, length of hospitalization, time to full weight-bearing, and any complications associated with lengthening. Radiographic review was done to determine the femoral limb-length discrepancy, amount lengthened, and any other complications. Patients being treated with the motorized nail were instructed to bear partial weight (£20 kg) with two crutches until consolidation was deemed adequate to allow full weight-bearing. Patients treated with circular external fixation were allowed to bear full weight during treatment; however, many did not do so because of pain and discomfort. The time to full weight-bearing was determined as the interval between surgery and the postoperative clinic visit at which the patient was permitted full weight-bearing.
For the purposes of this study, the treatment goal was to achieve at least 4 cm of lengthening without incurring a new abnormality. Most patients with congenital femoral deficiency had distal femoral valgus and external rotational deformities that were usually corrected either gradually or acutely as part of their treatment. However, in each case, the primary goal of treatment was limblengthening.
All complications were categorized according to the classification system developed at our institution (Table I) 31 . Categories are based on both the magnitude of the treatment necessary and the impact on the final outcome. Complications are graded retrospectively because their impact can only be determined after treatment is complete. A Category-I complication is one that required minimal or no change to the treatment plan, with the treatment goals still achieved. Examples include a pin-track infection treated with oral antibiotics or joint stiffness resolved by physical therapy. A Category-II complication is one that results in a substantial change in the treatment plan, but the goal of treatment is still achieved. Examples include delayed consolidation requiring additional intervention, device revision, or an unplanned return to surgery. A Category-III complication is defined as one that causes a failure to achieve the treatment goal or the development of a new pathology or permanent sequelae and is divided into two subtypes. A Category-IIIA complication is one in which the treatment goal is not achieved, but there is no new pathology. Anteroposterior radiograph of the femur made at the end of surgery. Note the retrograde insertion, proximal and distal locking bolts, and the cable leading from the base of the nail through a drill-hole in the lateral femoral condyle. This cable is connected at the time of surgery to the subcutaneously implanted radiofrequency receiver. To effect lengthening, radiofrequency waves are transmitted transcutaneously to the receiver, which converts them to electrical impulses discharged to the electric motor housed within the nail.
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Examples include a lengthening that is aborted for any reason. A Category-IIIB complication is one in which a new pathology is created, with or without achievement of the treatment goal. Examples include function-impairing joint stiffness, joint subluxation, a regenerate fracture with shortening and deformity, or a deep infection requiring systemic and/or surgical treatment. Any patient could incur more than one complication and could have more than one category of complication. Means and standard deviations, medians, and ranges were used to describe continuous variables, and the nonparametric Mann-Whitney test was used to compare the circular external fixator and motorized nail groups. A chisquare test was used to compare categorical variables between the groups. When the sample was small, a Fisher exact test was performed. Significance was set at p < 0.05.
Source of Funding
There was no external source of funding for this study.
Results
F
ourteen skeletally mature patients underwent fourteen femoral lengthening sessions with circular external fixation. Thirteen patients underwent fifteen retrograde femoral lengthening sessions using the motorized nail.
Data from our chart and radiographic review are summarized in Table II . The average age of the patients was 15.8 years (range, 12.3 to 18.8 years) in the circular external fixation group and 18.2 years (range, 15.5 to 21.2 years) in the motorized nail group. The average femoral discrepancy at the time of surgery was 8.4 cm (range, 4.5 to 17 cm) in the circular fixation group and 6.8 cm (range, 4 to 12 cm) in the motorized nail group. The average amount lengthened was 4.8 cm (range, 1.0 to 7.4 cm) in the circular fixator group and 4.4 cm (range, 1.5 to 7.0 cm) in the motorized nail group. The goal of at least 4 cm of lengthening was achieved in 71% of the circular external fixation group and in 73% of the motorized nail group.
As a charitable institution, we were able to provide patients the option of an extended hospital stay to supervise the lengthening process. The circular external fixator group had six extended stays among the fourteen lengthening procedures, whereas the motorized nail group had two extended stays among the fifteen procedures (p = 0.11). There was one unplanned readmission for physical therapy and pain management in each group. Overall, the median duration of hospitalization was 28.5 days (range, seven to 134 days) for patients treated with circular external fixation compared with eight days (range, four to 224 days) for the motorized nail group (p = 0.04). Excluding the patients who elected an extended hospital stay, the median duration of hospitalization was 9.5 days 1435
(range, seven to eighty-one days) for the circular external fixation group compared with seven days (range, four to 133 days) for the motorized nail group (p = 0.12). The average time to full weight-bearing was 8.8 months (range, 4.8 to 13.0 months) in the circular fixation group and 7.7 months (range, 4.4 to 11.7 months) in the motorized nail group (p = 0.27). The average length of follow-up was 3.6 years in the circular fixation group and 3.0 years in the motorized nail group. The severity and rate of complications for both groups are recorded in Tables III and IV . Since patients could have more than one complication and more than one category of complication, we analyzed the complication rate in two ways: the number of patients incurring specific categories of complications per lengthening session (Table III) and the total number of complications by category per lengthening session (Table IV) . Complications of varying severity occurred in all fourteen lengthening sessions (all fourteen patients) in the group that had circular external fixation and in eleven (73%) of fifteen lengthening sessions (thirteen patients) in the group treated with the motorized nail (p = 0.10) ( Table III) . Eleven of fourteen lengthening sessions (fourteen patients) in the circular fixation group were associated with Category-I complications compared with five (33%) of the fifteen lengthening sessions (thirteen patients) in the motorized nail group (p = 0.03). No significant difference was detected between the circular fixation and motorized nail groups with respect to the percentage of Category-II complications, with 43% (six complications) and 40% (six complications), respectively (p = 0.88), or with respect to the Category-IIIA complications, with 29% (four complications) and 20% (three complications) (p = 0.68). The rate of Category-IIIB complications in the motorized nail group (three; 20%) was lower than that in the circular fixation group (five; 36%); however, the difference was not significant (p = 0.43).
The average number of complications by category per lengthening session for both groups is summarized in Table IV . The average number of Category-I complications per lengthening session was 1.1 in the circular external fixation group compared with 0.4 in the motorized nail group (p = 0.02). The number of Category-II, IIIA, and IIIB complications per lengthening session was not significantly different between the treatment groups. The average total number of complications was 2.4 per lengthening session in the circular external fixation 
TABLE IV Comparison of the Number of Complications per Lengthening Session with Circular Fixation or Motorized Nail
Complication Category Circular Fixation* Motorized Nail* P Value *The values are given as the mean and the standard deviation, with the median and the range in parentheses. The circular fixation group included fourteen lengthening sessions in fourteen patients, and the motorized nail group included fifteen lengthening sessions in thirteen patients.
group compared with 1.2 per session in the motorized nail group (p = 0.02) (Table IV) . Eight patients had undergone eleven femoral lengthening sessions with circular external fixation prior to subsequent lengthening using the motorized nail (ten lengthening sessions). The rate of complications by category and the number of lengthening sessions associated with any complication (eleven of eleven sessions with circular external fixation and nine of ten sessions with the motorized nail) were comparable ( Table V) . The total number of complications averaged 2.6 during lengthening with circular external fixation compared with 1.6 during subsequent lengthening with the motorized nail (p = 0.03) (Table VI) .
In the circular external fixation group, there were four Category-IIIA complications, including premature consolidation with cessation of lengthening (one patient), an inability to tolerate the lengthening (two patients), and deformity of the regenerate bone (one patient). In the motorized nail group, there were three Category-IIIA complications, including an unrecognized settling of the telescopic rod that resulted in a decrease of the 4-cm lengthening that had been achieved to a final length increase of 2.5 cm in one patient. Another patient had a shift of the rod within the medullary canal that resulted in the need to abort the procedure after 1.5 cm of lengthening (Figs. 2-A and 2-B) . A third patient, who was noncompliant with the partial weight-bearing protocol, fell shortly after achieving the desired lengthening goal (4.5 cm) and incurred a segmental fracture with shortening. The motorized nail was Figs. 2-A and 2-B A patient who had failure to achieve the lengthening goal (a Category-IIIA complication). Fig. 2 -A Anteroposterior radiograph of the left femur demonstrating substantial varus deformity. The patient had two prior femoral lengthening procedures using a circular external fixator. Fig. 2 -B At three weeks postoperatively, the motorized nail had shifted within the patulous medullary canal, with bending of the proximal locking bolt.
Lengthening was ceased at this point.
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replaced with a retrograde trauma nail, and shortening to a 2.2-cm length increase was accepted (Figs. 3-A and 3-B) . None of these complications was device-specific.
In the circular fixation group, six Category-IIIB complications occurred in five patients during five lengthening sessions and included a regenerate fracture treated with open reduction and internal fixation (one patient); quadriceps contracture, with or without obligate patellar dislocation, requiring a quadricepsplasty (three patients); and a deep infection (two patients). Patients in the circular external fixation group with Category-IIIB complications had an average lengthening of 5.7 cm (range, 3.0 to 7.4 cm). The three Category-IIIB complications in the motorized nail group included the need for quadricepsplasty (two patients) and a deep intramedullary infection requiring serial debridement and antibiotic suppression during lengthening 
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(one patient). All three of these patients achieved lengthening of >5.0 cm.
Discussion
T he use of circular external fixation and gradual distraction of a fracture callus after osteotomy has extended the indications for limb-lengthening. Prolonged immobilization, difficulty with pin care, and a high rate of complications, however, have stimulated interest in improving limb-lengthening techniques. Lengthening with external fixation over an intramedullary nail, with locking of the nail at the end of the distraction period and removal of the external fixator, was popularized by Paley et al. 7 . They reported the results for twenty-nine patients who had lengthening with this technique compared with thirty-one who had lengthening using an Ilizarov circular fixator. They found that the group that had lengthening over a nail had reduced time in circular fixation, a decreased number of complications, fewer subsequent fractures, and earlier rehabilitation, although the overall final results were similar between the two groups.
The first fully implantable intramedullary lengthening device is attributed to Bliskunov 32 . Reports of totally implantable intramedullary lengthening devices include the Albizzia nail (DePuy, Villerubanne, France) 18, 20, 33 , the intramedullary skeletal kinetic distractor (ISKD; Orthofix, Lewisville, Texas) 34, 35 , FITBONE nails (Wittenstein Intens) 17, 18, 36 , and PRECICE nails (Ellipse Technologies, Irvine, California) [37] [38] [39] . The Albizzia and the ISKD nails rely on limb rotation to effect lengthening. The FITBONE and PRECICE are the only motorized intramedullary lengthening devices; the latter device has the added benefit of being reversible. The overall complication rate for intramedullary devices has been reported to range from 10% to 47% 17, 20, 33, 34, [37] [38] [39] [40] [41] [42] . Those studies included small numbers of patients, heterogeneous diagnoses, and both femoral and tibial lengthening sessions, and they lacked matched patients treated with external fixation.
Reporting of complications associated with limb-lengthening has been affected by heterogeneous patient populations and a lack of standardized categorization of complications. Donnan et al. utilized a complication classification system in a review of acute correction of lower limb deformity and limb-lengthening using circular fixation 4 . A grade-I complication had no longterm functional or anatomic importance and did not require surgery or anesthesia. A grade-II complication had no longterm importance, but surgery or anesthesia was needed to correct it. A grade-III complication had functional or anatomic impact but either resolved spontaneously or was correctable by surgery. A grade-IV complication was unresolvable by any standard treatment. Dahl et al. used a system in which complications were graded as minor, serious, and severe 2 . Paley used the terms problems (grade 1), obstacles (grade 2), and complications (grade 3), with problems indicating no operative intervention was required, obstacles meaning operative intervention was required, and complications indicating intraoperative injuries or issues had occurred and had not been resolved before the end of treatment. The complications were subdivided into major and minor complications 6 . The absence of a standardized complication classification limits the ability to compare complication rates across studies 5, 21 . It must be noted that the observations noted in our study are substantially impeded by the fact that the study is purely a retrospective chart and radiographic review, and many of those observations must be considered subjective in nature. In addition, the only clinically important and significant differences in the rate of complications were of the minor (Category-I) type (primarily pin-track infections). Our study included only skeletally mature patients with the diagnosis of congenital femoral deficiency who were treated under the same lengthening protocols at one institution and were carefully evaluated using a critical and comprehensive complication classification system. The patients treated with the motorized nail in our study were, on average, an extremely challenging patient group, with the majority having undergone one or more previous lengthening sessions by circular external fixation. Nevertheless, the patients treated with a motorized nail had a lower rate of complications than those treated with circular external fixation, and the patients who had previous circular fixator lengthening sessions had a lower complication rate after treatment with the motorized nail. Furthermore, the patients treated with a motorized nail had a shorter hospitalization, on average, and fewer required prolonged hospitalizations to supervise the lengthening procedure. The obligate retrospective nature of this study made evaluation of potentially confounding variables, such as individual patient selection, surgeon factors, and socioeconomic differences among patients, not feasible, and thus the findings must be considered as subjective observations only.
We had the impression that the patients treated with the motorized nail had, on average, substantially less pain after the initial postoperative period, required less intensive physical therapy supervision and intervention, and incurred less disruption in the activities of daily living than did those treated with circular external fixation. These observations, however, cannot be accurately quantified in a strictly retrospective chart and radiographic review and are purely subjective in nature. Furthermore, we had not employed other femoral lengthening methods (such as those involving monolateral or hexapod external fixators, or combined external and internal fixation) and thus cannot make direct comparison between outcomes of patients so treated and our patient population.
Using our complication classification scheme, a homogeneous pediatric population with congenital femoral deficiency treated with circular fixation and the motorized nail were compared in terms of outcomes and complications. Lengthening with the motorized nail decreased the number of complications compared with circular external fixation. This classification system can be used to quantify and qualify complications in limb-lengthening. A decreased rate of complications and improved outcomes may be realized with the use of motorized intramedullary lengthening devices in motivated patients with congenital femoral deficiency who require femoral lengthening. Although the specific intramedullary lengthening nail used in these patients did not have FDA approval, the overall positive experience encouraged us to continue to use FDA-approved intramedullary lengthening nails for the same indications. n
